GENEVA, Feb. 24 -- CYRUS THERAPEUTICS INC. (5th floor, 4 Jeongui-ro 8-gilSongpa-guSeoul 05836), (주) 사이러스테라퓨틱스 (서울특별시송파구정의로8길 4, 5층), KANAPH THERAPEUTICS INC. (5th floor, 3 Itaewon-ro 55ga-gilYongsan-guSeoul 04348), 주식회사 카나프테라퓨틱스 (서울특별시용산구이태원로55가길 3, 5층) filed a patent application (PCT/KR2025/012417) for "NOVEL COMPOUND HAVING SOS1 INHIBITORY ACTIVITY" on Aug 14, 2025. With publication no. WO/2026/...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.
